期刊文献+

复方氨酚美敏混悬剂的处方工艺优化

Optimization of the formulation and preparation process of compound paracetamol suspension
下载PDF
导出
摘要 制备复方氨酚美敏混悬剂,并进行处方工艺优化.以沉降体积比、再分散性、0.1 mol/L盐酸介质中对乙酰氨基酚(APAP)的溶出度、APAP晶型变化为评价指标,单因素考察助悬剂及用量、APAP原料粒径、胶态微晶纤维素(cMCC)剪切速度和时间、转速、温度,采用Box-Benhnken响应面法优化制剂处方工艺.优化的处方为:cMCC 0.12%、黄原胶0.064%、羧甲基纤维素钠(CMCNa) 0.097%.工艺筛选结果为:cMCC剪切速度1 2000 rpm、时间6 min,制剂搅拌速度为600 rpm,温度60℃.复方氨酚美敏混悬剂的处方工艺简单可行、稳定性较好. The aim of this experiment was to optimize the formulation and preparation process of compound paracetamol suspension.The sedimentation volume ratio, redispersibility, the dissolution of paracetamol(APAP) in 0.1mol/L hydrochloric acid medium, and the change of APAP crystal form were used as evaluation indicators.The type and amount of suspension, size of APAP raw material, shear rate and time of colloidal microcrystalline cellulose(cMCC),rotational speed and temperature were investigated by single factor;Box-Benhnken response surface methodology was used to optimize the formulation and preparation process.The optimized formulation was as follows: cMCC 0.12%,xanthan gum 0.064%,sodium carboxymethyl cellulose(CMCNa) 0.097%.The preparation process screening results were as follows: the shearing speedand time of cMCC are 12 000 rpm and 6 min, the stirring speed of preparation is 600 rpm, and the temperature is 60 ℃.The formulation and preparation process of compound paracetamol suspension is simple, feasible and stable.
作者 李鑫 宁星 代民言 苗利 高艺 LI Xin;NING Xing;DAI Min-yan;MIAO Li;GAO Yi(School of Pharmacy,Harbin University of Commerce,Harbin 150010,China)
出处 《西南民族大学学报(自然科学版)》 CAS 2023年第1期53-61,共9页 Journal of Southwest Minzu University(Natural Science Edition)
关键词 混悬剂 Box-Behnken设计-效应面法 工艺优化 suspension Box-Behnken design-response surface method process optimization
  • 相关文献

参考文献10

二级参考文献101

  • 1钱帅,张建军,高缘,周建平.纳米混悬剂研究进展[J].药学进展,2007,31(1):9-14. 被引量:16
  • 2侯新朴.物理化学[M].北京:人民卫生出版社,2008:288-291.
  • 3国家药品监督管理局执业药师资格认证中心.药学专业知识(二)[M].北京:中国中医药出版社,2003:121-123.
  • 4Li X, Gu L, Xu Y, et al. Preparation of fenofibrate nano- suspension and study of its pharmaeokinetic behavior in rats [J]. Drug Dev lnd Pharm, 2009, 35 (7) : 827-833.
  • 5Mishra PR, Shaal LA, Muller RH, et al. Production and characterization of hesperetin nanosuspensions for dermal delivery [J]. IntJPharm, 2009, 371 (1-2) : 182-189.
  • 6Radke M. Pure drug nanoparticles for the formulation of poorly soluble drugs [J]. New Drugs, 2001, 3 (1) : 62-68.
  • 7Engstrom JD, Tam JM, Miller MA, et al. Templated open floes of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers [J]. Pharm Res, 2009, 26(1): 101-117.
  • 8Makhlof A, Miyazaki Y, Tozuka Y, et al. Cyclodextrins as stabilizers for the preparation of drug nanocrystals by the emulsion solvent diffusion method [J]. lnt J Pharm, 2008, 357 (1-2) : 280-285.
  • 9Steckel H, Wehle S. A novel formulation technique for mete- red dose inhaler (MDI) suspensions [J]. Int J Pharm, 2004, 284 (1-2) : 75-82.
  • 10Lee J, Choi JY, Park CH. Characteristics of polymers enabling nano-comminution of water-insoluble drugs [J]. IntJPharm, 2008, 355 (1-2) : 328-336.

共引文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部